Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures

2.5 / 5 stars · 44/89 Roast Me

NIAGEN BIOSCIENCE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures

NIAGEN BIOSCIENCE, INC. (NAGE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 2.40 thousand shares for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.

Discontinued › Shareholders' Equity › Shares Granted or Issued, Share-Based Payment Arrangement › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2019-11-12

  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2019-09-30 was 803.00 shares, a 7200.00% increase year-over-year.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2019-06-30 was 352.00 shares, a 75.04% decline year-over-year.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2019-03-31 was 1.24K shares, a 18.82% increase year-over-year.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for the quarter ending 2018-09-30 was 11.00 shares, a 99.99% decline year-over-year.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2017 was 175.00K shares, a 337.50% increase from fiscal 2016.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2016 was 40.00K shares.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2016 was 0.00 shares, a 100.00% decline from fiscal 2015.
  • NIAGEN BIOSCIENCE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures for fiscal 2015 was 30.00K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 3 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 6 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 12 month as first filed
2019-09-30803.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12
1.16K shares
derived: sum of 2 quarters · filed 2019-11-12
2.40K shares
10-Q · filed 2019-11-12
2019-06-30352.00 shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
1.60K shares
10-Q · filed 2019-08-07
2019-03-311.24K shares
10-Q · filed 2019-05-09
2018-09-3011.00 shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07
1.42K shares
derived: sum of 2 quarters · filed 2018-11-07
2.47K shares
10-Q · filed 2018-11-07
-595.87K shares
derived: sum of 4 quarters · filed 2018-11-07
2018-06-301.41K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
2.46K shares
10-Q · filed 2018-08-09
-595.88K shares
derived: sum of 3 quarters · filed 2018-08-09
-515.88K shares
derived: sum of 4 quarters · filed 2018-08-09
2018-03-311.05K shares
10-Q · filed 2018-05-10
-597.29K shares
derived: sum of 2 quarters · filed 2018-05-10
-517.29K shares
derived: sum of 3 quarters · filed 2018-05-10
-377.29K shares
derived: sum of 4 quarters · filed 2018-05-10
2017-12-30-598.33K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
-518.33K shares
derived: sum of 2 quarters · filed 2018-03-15
-378.33K shares
derived: sum of 3 quarters · filed 2018-03-15
175.00K shares
10-K · filed 2018-03-15
2017-09-3080.00K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
220.00K shares
derived: sum of 2 quarters · filed 2017-11-09
773.33K shares
10-Q · filed 2017-11-09
234.19K shares
derived: sum of 4 quarters · filed 2018-03-15
2017-07-01140.00K shares
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10
693.33K shares
10-Q · filed 2017-08-10
154.19K shares
derived: sum of 3 quarters · filed 2018-03-15
581.66K shares
derived: sum of 4 quarters · filed 2018-03-15
2017-04-01553.33K shares
10-Q · filed 2017-05-11
14.19K shares
derived: sum of 2 quarters · filed 2018-03-15
441.67K shares
derived: sum of 3 quarters · filed 2018-03-15
2016-12-31-539.15K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
-111.67K shares
derived: sum of 2 quarters · filed 2018-03-15
40.00K shares
10-K · filed 2018-03-15
2016-10-01427.48K shares
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10
579.15K shares
10-Q · filed 2016-11-10
2016-07-02151.67K shares
10-Q · filed 2016-08-11
2016-01-020.00 shares
10-K · filed 2018-03-15
2015-01-03-60.00K shares
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
30.00K shares
10-K · filed 2017-03-16
90.00K shares
10-K · filed 2015-03-19
2014-09-2790.00K shares
10-Q · filed 2014-11-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87